Cypress Bioscience Inc (CYPB.W)
5.18USD
28 Jan 2010
$0.08 (+1.61%)
$5.18
--
$5.10
$4.96
237,423
299,624
$9.95
$4.91
CYPB.W
About
Overall
| Beta: | 0.79 |
| Market Cap (Mil.): | $193.78 |
| Shares Outstanding (Mil.): | 38.30 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| CYPB.W | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 1.96 | 3.76 |
| EPS (TTM): | -274.11 | -- | -- |
| ROI: | -17.87 | 0.92 | 2.30 |
| ROE: | -19.77 | 1.27 | 2.82 |
UPDATE 1-Cypress Bioscience Q3 loss narrower than expected
Nov 9 (Reuters) - Cypress Bioscience Inc posted a narrower-than-expected quarterly loss, helped by revenue from fibromyalgia drug Savella.
UPDATE 1-Cypress Bioscience posts Q4 loss on lower revenue
March 16 (Reuters) - Cypress Bioscience Inc posted a fourth-quarter loss, compared with a profit last year, as revenue plunged 84 percent and expenses rose.
UPDATE 1-Forest, Cypress delay launch of fibromyalgia drug
NEW YORK, March 6 (Reuters) - Forest Laboratories Inc and Cypress Bioscience Inc said on Friday that they were pushing back the U.S. launch of their fibromyalgia drug Savella while they seek approval for a minor cosmetic change.
Zoloft, Lexapro best new antidepressants-study
LONDON, Jan 29 (Reuters) - Pfizer Inc's Zoloft and Forest Laboratories Inc's Lexapro are the most effective and well-tolerated antidepressants among a group of 12 new drugs, according to an analysis published on Thursday.
UPDATE 2-Forest Labs results beat views, shares rise
NEW YORK, Jan 20 (Reuters) - Drugmaker Forest Laboratories Inc posted lower quarterly profit on Tuesday on charges for licensing new medicines, but operating results far exceeded analyst targets on lower-than-expected spending, sending shares up 3.7 percent.
STOCKS NEWS US-Marshall & Ilsley plummets after Q4 loss
Stocks on the move [HOT-RTRS] Real-time Equity news [U E] [RESF/US]
STOCKS NEWS US-Markets down on Citi, Bank of America
Stocks on the move [HOT-RTRS] Real-time Equity news [U E] [RESF/US]
STOCKS NEWS US-S&P Equity cuts price target on JPMorgan
Stocks on the move [HOT-RTRS] Real-time Equity news [U E] [RESF/US]
STOCKS NEWS US-Crude oil tumbles as recession deepens
Stocks on the move [HOT-RTRS] Real-time Equity news [U E] [RESF/US]
HEADLINE STOCKS-Some U.S. stocks on the move on Jan. 15
NEW YORK, Jan 15 (Reuters) - Some U.S. stocks on the move on Thursday:
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $17.88 | +0.04 |
| Eli Lilly & Co. (LLY.N) | $34.71 | +0.42 |
| Quest Diagnostics Incorporated (DGX.N) | $55.68 | +0.68 |
| Laboratory Corp. of America Holdings (LH.N) | $70.15 | +0.01 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
